Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis

Magnetic resonance imaging is a highly sensitive method for the detection of the lesions of multiple sclerosis and renders possible the study and the evolution of early lesions. Previous reports on magnetic resonance imaging following gandolinium‐diethylenetriamine pentaacetic acid (Gd‐DTPA) injection demonstrated that new lesions can be recognized by contrast enhancement. The pathological basis of these observations is uncertain. We have had the opportunity to study at autopsy the brain of a patient with chronic progressive multiple sclerosis who suffered acute worsening leading to death. Magnetic resonance imaging performed 10 days and 4 weeks prior to death showed new Gd‐DTPA‐enhanced lesions in the posterior hemispheric white matter adjacent to the lateral ventricles. Light microscopic examination of these areas demonstrated them to be fresh lesions comprising intense inflammatory activity and dense perivascular cuffs within an edematous lesion center and a striking parenchymal mononuclear cell infiltration at the margins of the lesions. Lesions that were demonstrated by increased signal on T2‐weighted images, but were not enhanced following administration of Gd‐DTPA, were all of the chronic type, either inactive or active. None of these showed the intense inflammatory activity of the acute lesions and most displayed fibrous astrogliosis.

[1]  C. Raine,et al.  Multiple sclerosis. Interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, nondemyelinating conditions. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[2]  A. Thompson,et al.  High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[3]  F. Barkhof,et al.  A correlative triad of gadolinium‐DTPA MRI, EDSS, and CSF‐MBP in relapsing multiple sclerosis patients treated with high‐dose intravenous methylprednisolone , 1992, Neurology.

[4]  D. Thomas,et al.  A Gibbs sampling approach to linkage analysis. , 1992, Human heredity.

[5]  R. Murray,et al.  The effect of high‐dose steroids on MRI gadolinium enhancement in acute demyelinating lesions , 1991, Neurology.

[6]  C. Raine Multiple sclerosis: a pivotal role for the T cell in lesion development , 1991, Neuropathology and applied neurobiology.

[7]  P. Scheltens,et al.  Quantitative MRI changes in gadolinium‐DTPA enhancement after high‐dose intravenous methylprednisolone in multiple sclerosis , 1991, Neurology.

[8]  H Okazaki,et al.  Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. , 1991, Radiology.

[9]  N. Patronas,et al.  Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: Implications for clinical trials and natural history , 1991, Annals of neurology.

[10]  E P du Boulay,et al.  Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. , 1991, Brain : a journal of neurology.

[11]  C. Brosnan,et al.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.

[12]  G. Barnett,et al.  Stereotactic biopsy of an active multiple sclerosis lesion. Immunocytochemical analysis and neuropathologic correlation with magnetic resonance imaging. , 1990, Archives of neurology.

[13]  B E Kendall,et al.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.

[14]  D. Wolinsky,et al.  Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double‐blinded, placebo‐controlled clinical trial , 1990 .

[15]  C. Pozzilli,et al.  Serial study of gadolinium‐DTPA MRI enhancement in multiple sclerosis , 1990, Neurology.

[16]  D. N. Landon,et al.  Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. , 1990, Brain : a journal of neurology.

[17]  E. Cho,et al.  Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[18]  Robert T. Leshner,et al.  Remyelination in the Human Central Nervous System , 1989, Journal of neuropathology and experimental neurology.

[19]  L. Scheinberg,et al.  On the immunopathology of plaque development and repair in multiple sclerosis , 1988, Journal of Neuroimmunology.

[20]  H I Goldberg,et al.  Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. , 1988, Radiology.

[21]  B E Kendall,et al.  Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. , 1988, Brain : a journal of neurology.

[22]  U. Stendahl,et al.  Haptoglobin groups in ovarian carcinoma. , 1988, Human heredity.

[23]  C. Polman,et al.  Low-dose cyclosporin A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat , 1988, Journal of Neuroimmunology.

[24]  A. A. Eisen,et al.  MRI in the diagnosis of MS , 1988, Neurology.

[25]  B E Kendall,et al.  The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. , 1987, Brain : a journal of neurology.

[26]  S W Atlas,et al.  Multiple sclerosis: gadolinium enhancement in MR imaging. , 1986, Radiology.

[27]  L. Kaufman,et al.  Nuclear magnetic resonance imaging in multiple sclerosis , 1983, Annals of neurology.

[28]  A. S. Hall,et al.  NUCLEAR MAGNETIC RESONANCE IMAGING OF THE BRAIN IN MULTIPLE SCLEROSIS , 1981, The Lancet.

[29]  R. Adams,et al.  The morbid anatomy of the demyelinative diseases , 1952 .